These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26518190)

  • 1. Postprandial hyperglycemia was ameliorated by taking metformin 30 min before a meal than taking metformin with a meal; a randomized, open-label, crossover pilot study.
    Hashimoto Y; Tanaka M; Okada H; Mistuhashi K; Kimura T; Kitagawa N; Fukuda T; Majima S; Fukuda Y; Tanaka Y; Yamada S; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Nakamura N; Fukui M
    Endocrine; 2016 May; 52(2):271-6. PubMed ID: 26518190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
    Hansen LS; Gasbjerg LS; Brønden A; Dalsgaard NB; Bahne E; Stensen S; Hellmann PH; Rehfeld JF; Hartmann B; Wewer Albrechtsen NJ; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2024 Aug; 191(2):192-203. PubMed ID: 39049802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
    Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
    Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
    Deane AM; Nguyen NQ; Stevens JE; Fraser RJ; Holloway RH; Besanko LK; Burgstad C; Jones KL; Chapman MJ; Rayner CK; Horowitz M
    J Clin Endocrinol Metab; 2010 Jan; 95(1):215-21. PubMed ID: 19892837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.
    Vollmer K; Gardiwal H; Menge BA; Goetze O; Deacon CF; Schmidt WE; Holst JJ; Meier JJ
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1379-85. PubMed ID: 19174495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: A randomized cross-over pilot study.
    Sato D; Morino K; Ogaku S; Tsuji A; Nishimura K; Sekine O; Ugi S; Maegawa H
    J Diabetes Investig; 2019 Sep; 10(5):1284-1290. PubMed ID: 30688410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.
    Vella A; Bock G; Giesler PD; Burton DB; Serra DB; Saylan ML; Dunning BE; Foley JE; Rizza RA; Camilleri M
    Diabetes; 2007 May; 56(5):1475-80. PubMed ID: 17303799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
    Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
    Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Pre-Meal Metformin With or Without an Acute Exercise Bout on Postprandial Lipemic and Glycemic Responses in Metabolic Syndrome Patients: A Randomized, Open Label, Crossover Study.
    Methnani J; Hajbelgacem M; Ach T; Chaieb F; Sellami S; Bouslama A; Zaouali M; Omezzine A; Bouhlel E
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231156318. PubMed ID: 36802839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with Type 2 diabetes mellitus.
    Thondam SK; Cross A; Cuthbertson DJ; Wilding JP; Daousi C
    Diabet Med; 2012 Aug; 29(8):e205-10. PubMed ID: 22486277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial glucose, insulin and glucagon-like peptide 1 responses to sucrose ingested with berries in healthy subjects.
    Törrönen R; Sarkkinen E; Niskanen T; Tapola N; Kilpi K; Niskanen L
    Br J Nutr; 2012 May; 107(10):1445-51. PubMed ID: 21929838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.
    Østoft SH; Bagger JI; Hansen T; Hartmann B; Pedersen O; Holst JJ; Knop FK; Vilsbøll T
    Eur J Endocrinol; 2015 Aug; 173(2):205-15. PubMed ID: 25953829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of consumption of main and side dishes with white rice on postprandial glucose, insulin, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 responses in healthy Japanese men.
    Kameyama N; Maruyama C; Matsui S; Araki R; Yamada Y; Maruyama T
    Br J Nutr; 2014 May; 111(9):1632-40. PubMed ID: 24507870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.
    Calanna S; Christensen M; Holst JJ; Laferrère B; Gluud LL; Vilsbøll T; Knop FK
    Diabetologia; 2013 May; 56(5):965-72. PubMed ID: 23377698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.
    Trahair LG; Horowitz M; Stevens JE; Feinle-Bisset C; Standfield S; Piscitelli D; Rayner CK; Deane AM; Jones KL
    Diabetologia; 2015 Aug; 58(8):1769-78. PubMed ID: 26048234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the timing and the administration of acarbose on postprandial hyperglycaemia.
    Rosak C; Nitzsche G; König P; Hofmann U
    Diabet Med; 1995 Nov; 12(11):979-84. PubMed ID: 8582130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.